Abstract
Vulvovaginal candidiasis is one of the frequent vaginal infections in women caused by Candida albicans. We evaluate the expression of ERG11, CDR1 and CDR2 genes by quantitative RT-PCR in Candida albicans strains isolated from women in north of Iran. Of 50 samples, 23 (46%) were determined to be Candida albicans strains. In phenotypic assays, 20 (~87%) of strains were resistant to doses of fluconazole (≥128–2048 μg/mL). Also, 43.47 and 26.08% of isolates were resistant to ketoconazole and clotrimazole, respectively. Overexpression or mutation of ERG11 and upregulation of CDR1 and CDR2 genes was found in some resistant isolates compared to strain ATCC10231. Multidrug resistance in in the isolates was due to the upregulation of abovementioned genes as well as decreased affinity of ERG11 to azoles. Thus, we need to new strategies and drugs to treat vulvovaginitis in Guilan’s women.
Similar content being viewed by others
REFERENCES
Silva, A.P., Miranda, I.M., Guida, A., Synnott, J., Rocha, R., Silva, R., Amorim, A., Pina-Vaz, C., Butler, G., and Rodrigues, A.G., Transcriptional profiling of azole-resistant Candida parapsilosis strains, Antimicrob. Agents Chemother., 2011, vol. 55, pp. 3546–3556.
Asai, K., Tsuchimori, N., Okonogi, K., Perfect, J.R., Gotoh, O., and Yoshida, Y., Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450, Antimicrob. Agents Chemother., 1999, vol. 43, pp. 1163–1169.
Wang, B., Huang, L.-H., Zhao, J.-X., Wei, M., Fang, H., Wang, D.-Y., Wang, H.-F., Yin, J.-G., and Xiang, M., ERG11 mutations associated with azole resistance in Candida albicans isolates from vulvovaginal candidosis patients, Asian Pac. J. Trop. Biomed., 2015, vol. 5, pp. 909–914.
Chen, L.M., Xu, Y.H., Zhou, C.L., Zhao, J., Li, C.Y., and Wang, R., Overexpression of CDR1 and CDR2 genes plays an important role in fluconazole resistance in Candida albicans with G487T and T916C mutations, J. Int. Med. Res., 2010, vol. 38, pp. 536–545.
Ge, S.H., Wan, Z., Li, J., Xu, J., Li, R.Y., and Bai, F.Y., Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China, Antimicrob. Agents Chemother., 2010, vol. 54, pp. 3126–3131.
Harriott, M.M., Lilly, E.A., Rodriguez, T.E., Fidel, P.L., Jr., and Noverr, M.C., Candidaalbicans forms biofilms on the vaginal mucosa, Microbiology, 2010, vol. 156, pp. 3635–3644.
Balabandi, S., Khazaei-Koohpar, Z., and Ranji, N., Correlation between ERG11 gene mutations and fluconazole resistance in Candida albicans strains isolates isolated in from Rasht in 2015–2016 years, Arak Med. Univ. J., 2017, vol. 20, pp. 13–22.
Pfaller, M.A., Diekema, D.J., Rex, J.H., Espinel-Ingroff, A., Johnson, E.M., Andes, D., Chaturvedi, V., Ghannoum, M.A., Odds, F.C., Rinaldi, M.G., Sheehan, D.J., Troke, P., Walsh, T.J., and Warnock, D.W., Correlation of MIC with outcome for Candida species tested against voriconazole: Analysis and proposal for interpretive breakpoints, J. Clin. Microbiol., 2006, vol. 44, pp. 819–826.
Williams, D.W., Jordan, R.P., Wei, X.Q., Alves, C.T., Wise, M.P., Wilson, M.J., and Lewis, M.A., Interactions of Candida albicans with host epithelial surfaces, J. Oral Microbiol., 2013, vol. 5. https://doi.org/10.3402/jom.v5i0.22434
Sobel, J.D., Recurrent vulvovaginal candidiasis, Am. J. Obstet. Gynecol., 2016, vol. 214, pp. 15–21.
Liu, J.Y., Shi, C., Wang, Y., Li, W.J., Zhao, Y., and Xiang, M.J., Mechanisms of azole resistance in candida albicans clinical isolates from, Shanghai: China, Res. Microbiol., 2015, vol. 166, pp. 153–161.
White, T.C., Holleman, S., Dy, F., Mirels, L.F., and Stevens, D.A., Resistance mechanisms in clinical isolates of Candida albicans, Antimicrob. Agents Chemother., 2002, vol. 46, pp. 1704–1713.
Cernicka, J. and Subik, J., Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis, Int. J. Antimicrob. Agents, 2006, vol. 27, pp. 403–408.
Flowers, S.A., Colon, B., Whaley, S.G., Schuler, M.A., and Rogers, P.D., Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans, Antimicrob. Agents Chemother., 2015, vol. 59, pp. 450–460.
Henry, K.W., Nickels, J.T., and Edlind, T.D., Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors, Antimicrob. Agents Chemother., 2000, vol. 44, pp. 2693–2700.
Tavakoli, M., Zaini, F., Kordbacheh, M., Safara, M., Raoofian, R., and Heidari, M., Upregulation of the ERG11 gene in Candida krusei by azoles, Daru, 2010, vol. 18, pp. 276–280.
Funding
This study was financially supported by the Vice-Chancellorship of Research and Technology, Guilan University of Medical Science and Islamic Azad University (Rasht branch).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interest.
Statement of compliance with standards of research involving humans as subjects. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants involved in the study.
About this article
Cite this article
Najmeh Ranji, Sharami, S.H., Golpour, H. et al. Molecular Aspect of Drug Resistance in Candida albicans Isolates of Women with Vulvovaginal Candidiasis. Mol. Genet. Microbiol. Virol. 35, 117–122 (2020). https://doi.org/10.3103/S0891416820020081
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0891416820020081